Remi Laberge

Company: Arda Therapeutics

Job title: CTO

Seminars:

Antibody-Drug Conjugates as Antifibrotic: Depleting Disease-Driving Cells 1:00 pm

Explore the use of single cell and spatial transcriptomics to identify pathogenic fibroblasts. Discuss the development of ADCs that selectively target pathogenic fibroblast populations driving fibrosis across organs Evaluate the translational potential of fibroblast-depleting ADCs across fibrotic diseases through various preclinical models.Read more

day: Conference Day Two